Back to search

Hepatic Considerations in the Use of Antiepileptic Drugs

Data up to Jan 2025

Published1987
Citations101
References18

Total Citations Per Year

Abstract

References (18)

ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA A DISEASE ENTITY IN CHILDHOOD

1963 • 815 citations

Valproic acid hepatic fatalities

1987 • 491 citations

Valproate-Induced Hepatic Injury: Analyses of 23 Fatal Cases

2007 • 389 citations

Cytochrome P-450—Catalyzed Formation of Δ 4 -VPA, a Toxic Metabolite of Valproic Acid

1987 • 248 citations

Predisposition to Phenytoin Hepatotoxicity Assessed in Vitro

1981 • 235 citations

Hypoglycin and hypoglycin-like compounds.

1969 • 153 citations

Hepatic Injury Associated with Diphenylhydantoin Therapy. A Clinicopathologic Study of 20 Cases

1980 • 117 citations

Acetaminophen hepatotoxicity

1980 • 108 citations

A Direct Hepatotoxic Effect of Valproic Acid

1979 • 102 citations

Production of the Features of Reye's Syndrome in Rats with 4-Pentenoic Acid

1975 • 100 citations

Granulomatous Hepatitis Secondary to Carbamazepine

1981 • 70 citations

Fatal carbamazepine hepatitis

1977 • 68 citations

Phenytoin hepatotoxicity

1979 • 68 citations

A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: Possible clinical significance

1985 • 58 citations

Hepatic toxicity of antiepileptic drugs: A review

1983 • 42 citations

A direct hepatotoxic effect of valproic acid

1979 • 32 citations

Carbamazepine-induced acute cholangitis

1987 • 25 citations

Barbiturate-induced submassive hepatic necrosis. Report of a case and review of the literature.

1980 • 17 citations

Cited By (0)

No citing papers found in database

Hepatic Considerations in the Use of Antiepileptic Drugs (1987) – Epilepsia | Metascience Observatory Explorer